Akebia Therapeutics, Inc (AKBA) Stock Price

1.76 ▼ -0.09 (-4.86%)
Open: 1.82 Vol: 3.77M Day's range: 1.75 - 1.83 Nov 13, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
AKBA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.77▼ 1.77▼ 1.77▼ 1.83▼ 2.39▼
MA10 1.77▼ 1.78▼ 1.80▼ 1.97▼ 2.61▼
MA20 1.78▼ 1.81▼ 1.81▼ 2.42▼ 3.04▼
MA50 1.78▼ 1.77▼ 1.89▼ 2.68▼ 2.62▼
MA100 1.80▼ 1.91▼ 2.18▼ 3.10▼ 2.03▼
MA200 1.81▼ 2.24▼ 2.55▼ 2.75▼ 1.45▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.002▼ -0.006▼ 0.001▲ -0.063▼ -0.184▼
RSI 30.687▼ 39.294▼ 40.837▼ 30.309▼ 31.007▼
STOCH 29.167     22.840     14.797▼ 20.443     24.862    
WILL %R -100.000▼ -100.000▼ -100.000▼ -88.344▼ -89.840▼
CCI -274.510▼ -90.234     -93.547     -88.560     -233.336▼
Latest Filters Detected On AKBA
BBANDS $AKBA Bollinger Bands Expanding Set Alert
CDL $AKBA Evening Star Candlestick Pattern Detected Set Alert
CDL $AKBA Marubozu Candlestick Pattern Detected Set Alert
Akebia Therapeutics, Inc News
Akebia Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Monday, November 10, 2025 04:21 AM
Q3 2025 net product revenues grew to $14.3 million; Q3 2025 total net product revenues were $56.8 millionOperational pilot ...
An Overview of Akebia Therapeutics's Earnings
Friday, November 07, 2025 07:04 AM
Shares of Akebia Therapeutics were trading at $2.01 as of November 06. Over the last 52-week period, shares are up 1.26%. Given that these returns are generally positive, long-term shareholders are ...
Vafseo® (vadadustat) Dialysis Dependent Patient Post Hoc Data Analysis: Composite of All-Cause Mortality and Hospitalization Outcomes Statistically More Favorable for Patients ...
Thursday, November 06, 2025 04:11 PM
Win-Odds Analysis Presented at American Society of Nephrology Kidney Week 2025CAMBRIDGE, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company ...
AKBA historical stock data
date open high low close volume
13/11/25 1.82 1.83 1.75 1.76 3,767,220
12/11/25 1.82 1.89 1.77 1.85 4,436,049
11/11/25 1.68 1.84 1.67 1.81 5,189,379
10/11/25 1.73 1.75 1.57 1.67 16,762,309
07/11/25 2.02 2.07 1.9601 2.04 4,475,761
06/11/25 2.11 2.11 1.98 2.01 4,130,211
05/11/25 2.08 2.13 2.0625 2.12 3,070,674
04/11/25 2.10 2.145 2.07 2.09 5,465,754
03/11/25 2.20 2.22 2.065 2.12 4,254,707
31/10/25 2.11 2.23 2.07 2.21 6,112,330
Quote Details
52wk Low:1.52
52wk High:4.079
Vol:3.77M
Avg Vol(3m):74.3M
1Y Chng:-14.56%
1M Chng:-37.81%
Add to Watch List
More Information
Index US Composite
Market Cap. 490.93M